Developer: Exubrion Therapeutics (currently available for veterinary use only) Description 117mSn-HTC, also known as 117mSn-Tin Colloid, 117mSn-Homogeneous Tin-117m Colloid, or Synovetin OA™, is a radiopharmaceutical agent developed by Exubrion Therapeutics, a subsidiary of Serene LLC. The compound is marketed under the brand name Synovetin OA™ for veterinary use as a… Continue Reading…
Alzheimer’s disease (AD) is the most relevant form of dementia and an early and accurate diagnosis is not possible by clinical symptoms. Only at a late stage of the disease do symptoms allow a rough differentiation from other neurodegenerative diseases. A confirmation of AD can only be given by postmortem… Continue Reading…
European Journal of Nuclear Medicine and Molecular Imaging (2021) 48:1680–1681 E. Mairal1 & B. Barberon2 & N. Laine2 & M. Coulange2 & Eric Guedj3 1 Department of Nuclear Medicine and Nancyclotep Imaging, Platform, CHRU Nancy, Université de Lorraine,54000 Nancy, France2 APHM, INSERM 1263 – INRA 1260, TEAM V: Adenosinergic System… Continue Reading…